Sage Journals: Discover world-class research

Free access

Research article

First published 2024-9

Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis

Maria-Ioanna Stefanou, Aikaterini Theodorou, Konark Malhotra [...]

European Stroke Journal

Open access

Review article

First published 2024

Risk of major adverse cardiovascular events and all-cause mortality under treatment with GLP-1 RAs or the dual GIP/GLP-1 receptor agonist tirzepatide in overweight or obese adults without diabetes: a systematic review and meta-analysis

Maria-Ioanna Stefanou, Lina Palaiodimou, Aikaterini Theodorou [...]

Therapeutic Advances in Neurological Disorders

Free access

Research article

First published 2020-04-03

The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson’s Disease

Lingyu Zhang, Liping Zhang, Yanwei Li [...]

Journal of Parkinson’s Disease

Open access

Case report

First published 2025-04

Glucagon-like Peptide-1 Receptor Agonists (GLP-1-RA) and GLP-1/Gastrointestinal Peptide RA (GLP-1/GIP-RA) Use in Adolescents and Young Adults with Type 1 Diabetes and Overweight or Obesity

Chiara M. Lopach, Tyler J. Dobbs, Claire Zimmerman [...]

Diabetes Technology and Obesity Medicine

Retricted access

Research article

First published 2025-12

Clinical Outcomes of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) and Glucagon-Like Peptide-1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (GLP-1/GIP RA) Exposures Presenting to the Emergency Department

Hayley T. Gartner, Reeves E. Simmons, Herbert Z. Wan [...]

Annals of Pharmacotherapy

Open access

Case report

First published 2025

Preservation of lean soft tissue during weight loss induced by GLP-1 and GLP-1/GIP receptor agonists: A case series

Grant M. Tinsley, Spencer Nadolsky

Sage Open Medical Case Reports

Open access

Research article

First published 2020

The Dual GLP-1/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP/PS1 Mouse Model of Alzheimer’s Disease

Mark Maskery, Elizabeth Mary Goulding, Simon Gengler [...]

American Journal of Alzheimer's Disease & Other Dementias®

Retricted access

Research article

First published 2021-09-14

A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer’s Disease 1

Hong-Yan Cai, Dan Yang, Jing Qiao [...]

Journal of Alzheimer’s Disease

Open access

Research article

First published 2025-9

2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists

Samantha L Hocking, David A Scott, Matthew L Remedios [...]

Anaesthesia and Intensive Care

Free access

Correction

First published 2023-08-15

Erratum to: A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer’s Disease

Hong-Yan Cai, Dan Yang, Jing Qiao [...]

Journal of Alzheimer’s Disease

Search results